Smart Theranostic Lipid-Based Nanoparticles for Breast Cancer Treatment Using Hydrophobic Cytostatics
ISEF · 2023 Materials Science
Overview
Liposome is a spherical lipid-based nanoparticle comprised of a phospholipid bilayer and an inner aqueous core. Liposomes create an environment ideal for encapsulating cytostatics, which brings a non-invasive method for more effective breast cancer treatment due to the targeted delivery of therapeutics. My research intended to produce stable liposomal nanoparticles and encapsulate the hydrophobic drug docetaxel. Docetaxel was encapsulated during liposome formulation using an ethanol injection technique. Nanoparticles were characterised to obtain fundamental data (size, zeta potential and concentration). I further measured their long-term size stability for up to 30 days and tested their resilience in 2 environments simulating human plasma (RS) and intracellular acetic fluid (ICA) during a 24-hour period. The produced liposomes were uniform with an average size of 89±13 nm and PdI 0.119±0.046. Zeta potential showed neutral values (-2.93±4.6 mV). The measured absorbance of liposomes was used to calculate the absolute concentration of docetaxel (3.8 mg/ml) and concentration of nanoparticles (10.4 mg/ml). Liposomes retained their size with a small rise in PdI throughout the 30 days. However, the PdI was still up to 0.2, which refers to uniform nanoparticles. Furthermore, they maintained their size and charge throughout 24 hours in both environments simulating body fluids. In RS, PdI increased after 24 hours (0.059 to 0.183) with a higher size peak, which indicates possible fusing or aggregation of nanoparticles. The results confirmed an excellent production of liposomes in a suitable and stable form. Produced particles are especially beneficial in further research on breast cancer therapy using hydrophobic cytostatics.
Competition history
- ISEF 2023
Resources
Related projects
ISEF · 2020
Targeted Breast Cancer Therapy Using Nanoparticles Modified by Tumor-Homing Peptides
ISEF · 2014
Lipoproteins as a Vehicle for Targeted and Selective Delivery of Hydrophobic Drugs to Cancer Cells
ISEF · 2024
TNBCnano: Novel Layer-By-Layer Nanoparticles for Systemic Combination Delivery of MRP1 siRNA and Doxorubicin for Triple-Negative Breast Cancer Treatment
ISEF · 2018
Lipoprotein-based Therapeutic Approach to Combat Breast Cancer
Closest projects by meaning, across every fair and year in the corpus.
Source: Regeneron International Science and Engineering Fair